FDA Inspection 1329552 — Gustavo Vasili Lucas, MD

Gustavo Vasili Lucas, MD — FEI 3043413562

The FDA completed an inspection of Gustavo Vasili Lucas, MD on Jul 17, 2026 in Curitiba. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 17, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Curitiba (Brazil)

Additional Details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.